CRISPR Therapeutics
CRSP
#3195
Rank
A$5.83 B
Marketcap
$67.98
Share price
-3.71%
Change (1 day)
-45.71%
Change (1 year)

CRISPR Therapeutics (CRSP) - Total debt

Total debt on the balance sheet as of December 2024 : A$0.35 Billion

According to CRISPR Therapeutics's latest financial reports the company's total debt is A$0.35 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

CRISPR Therapeutics - Total debt on balance sheet (from 2015 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.35 B-2.32%
2022-12-31A$0.35 B15.53%
2021-12-31A$0.31 B288.53%
2020-12-31A$79.88 M6.46%
2019-12-31A$75.04 M
2018-12-31N/A
2015-12-31A$52.62 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$5.11 M-98.58%๐Ÿ‡บ๐Ÿ‡ธ USA